Pacira BioSciences' Net Cash Flow fell 13965.07% to -$153.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$98.7 million, marking a year-over-year decrease of 167.22%. This contributed to the annual value of $123.5 million for FY2024, which is 151.18% up from last year.
According to the latest figures from Q3 2025, Pacira BioSciences' Net Cash Flow is -$153.0 million, which was down 1,017.98% from $16.7 million recorded in Q2 2025.
Over the past 5 years, Pacira BioSciences' Net Cash Flow peaked at $451.5 million during Q4 2021, and registered a low of -$358.8 million during Q1 2022.
Moreover, its 3-year median value for Net Cash Flow was $16.7 million (2025), whereas its average is $3.9 million.
Per our database at Business Quant, Pacira BioSciences' Net Cash Flow soared by 1,885.67% in 2021 and then slumped by 13,965.07% in 2025.
Over the past 5 years, Pacira BioSciences' Net Cash Flow (Quarterly) stood at $451.5 million in 2021, then crashed by 101.17% to -$5.3 million in 2022, then spiked by 1,125.15% to $54.2 million in 2023, then tumbled by 43.13% to $30.8 million in 2024, then plummeted by 13,965.07% to -$153.0 million in 2025.
Its Net Cash Flow stands at -$153.0 million for Q3 2025, versus $16.7 million for Q2 2025 and $6.8 million for Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value